AESKULISA tTg-G New Generation 30-7504US

GUDID 04250289502887

The AESKULISA tTg-G New Generation is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgG antibodies against neo-ep

Aesku.Diagnostics GmbH & Co. KG

Tissue transglutaminase antibody IVD, kit, enzyme immunoassay (EIA)
Primary Device ID04250289502887
NIH Device Record Key418f6734-cbff-4c24-ac5b-e7442a168294
Commercial Distribution StatusIn Commercial Distribution
Brand NameAESKULISA tTg-G New Generation
Version Model Number30-7504US
Catalog Number30-7504US
Company DUNS341714388
Company NameAesku.Diagnostics GmbH & Co. KG
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS104250289502887 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

MVMAutoantibodies, Endomysial(Tissue Transglutaminase)

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number3
Public Version Date2018-07-06
Device Publish Date2017-02-21

On-Brand Devices [AESKULISA tTg-G New Generation ]

04250289503136The AESKULISA tTg-G New Generation is a solid phase enzyme immunoassay for the quantitative and
04250289502887The AESKULISA tTg-G New Generation is a solid phase enzyme immunoassay for the quantitative and

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.